Finding Relief from Opioid-Induced Constipation: Emerging Therapies for Individualized Management

Sponsored by an educational grant from Salix Pharmaceuticals, Inc., A Division of Valeant Pharmaceuticals North America LLC and Consultant, a registered trademark of HMP Communications

Date
Saturday, September 9

Start Time
7:00a

End Time
8:00a

Room
Gracia 1
Level 3

Learning Objectives

  • Recognize the prevalence, burden, and barriers to care faced by chronic pain patients with OIC
  • Discuss the latest criteria for the screening and diagnosis of OIC in patients with chronic pain managed by opioids
  • Evaluate the full OIC treatment armamentarium--including emerging targeted therapies--in terms of mechanism of action, safety, and efficacy
  • Develop tailored treatment plans that apply the latest consensus recommendations and prescription therapies to effectively manage OIC

Faculty
Jeffrey A. Gudin, MD

Registration Website
http://www.naccme.com/program/2017-783

Contact Name
MaryEllen Fama

Contact Phone
(609) 630-6205

Contact email
mfama@naccme.com

Share:

Related Content